reports
- GlobalData Healthcare Department
Juno Therapeutics Inc (JUNO) - Financial and Strategic SWOT Analysis R...
Juno Therapeutics Inc (JUNO) - Financial and Strategic SWOT Analysis Review Summary Juno Therapeutics Inc (Juno) is a clinical-stage company that develops novel cellular immunotherapies. The company formulates cell-based cancer immunotherapies based on platforms such as chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to identify and kill cancer cells. Juno Therapeutics Inc Key Recent Developments: Aug 09,2017: Editas Medicine Achieves ...
- GlobalData Healthcare Department
Juno Therapeutics Inc (JUNO) - Financial Analysis Review
Juno Therapeutics Inc (JUNO) - Financial Analysis Review Summary Juno Therapeutics Inc (Juno) is a clinical-stage company that develops novel cellular immunotherapies. The company formulates cell-based cancer immunotherapies based on platforms such as chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to identify and kill cancer cells. GlobalData's Juno Therapeutics Inc (JUNO) - Financial Analysis Review provides a comprehensive insight in...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.